Niu et al. first reported that CAN attenuated NLRP3 inflammasome-mediated inflammation in immune cells by inhibiting NF-κB signaling and upregulating Bif-1, providing a new idea for the anti-inflammatory effect of CAN [10]. Here, NFKB1 is linked to Crouzon syndrome-acanthosis nigricans syndrome.